ConductScience.org, home

Paper11368258

Effect of metronidazole on the growth of vaginal lactobacilli in vitro.

Simoes JA and 3 others. Infect Dis Obstet Gynecol, 2001. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Papers, record 11368258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11368258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of metronidazole on the growth of vaginal lactobacilli in vitro.
PubMed
Journal
Infect Dis Obstet Gynecol
PubMed
Year
2001
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
1.11
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Simoes JAJ A
2Aroutcheva AAA A
3Shott SS
4Faro SS

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
LactobacillusMajor topic
MetronidazoleMajor topic
VaginaMajor topic
Dose-Response Relationship, Drug
Female
Humans
Statistics, Nonparametric

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16465238Analysis of metronidazole penetration into vaginal fluid by reversed-phase high-performance liquid chromatography.Am J Obstet Gynecol1984https://conductscience.org/library/papers/6465238PubMed
210908773Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial.Obstet Gynecol2000https://conductscience.org/library/papers/10908773PubMed
3727761Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/727761PubMed
410100770Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis.Sex Transm Dis1999https://conductscience.org/library/papers/10100770PubMed
58141197Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment.Am J Obstet Gynecol1994https://conductscience.org/library/papers/8141197PubMed
68497364Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis.Obstet Gynecol1993https://conductscience.org/library/papers/8497364PubMed
717035761Bacterial vaginosis: sequelae and management.Curr Opin Infect Dis1999https://conductscience.org/library/papers/17035761PubMed
88440952Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin.J Infect Dis1993https://conductscience.org/library/papers/8440952PubMed
97876396Pharmacokinetics of intravaginal metronidazole gel.J Clin Pharmacol1994https://conductscience.org/library/papers/7876396PubMed
107502179The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli.Sex Transm Dis1995https://conductscience.org/library/papers/7502179PubMed
11708015Inactivation of metronidazole by anaerobic and aerobic bacteria.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/708015PubMed

Download CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
425513283D cell assemblies for controlled evaluation of response to dual agent delivery nanofibers targeting bacterial vaginosis.Biomater Adv2026https://conductscience.org/library/papers/42551328PubMed
42190999Electrospun nanofibers for antibiotic and probiotic co-delivery to target bacterial vaginosis.Int J Pharm2026https://conductscience.org/library/papers/42190999PubMed
41740442The effects of drinking water with essential oils-organic acids blend replacing preventive antibiotics during withdrawal period on growth performance and gut health of broilers in a commercial farm.Poult Sci2026https://conductscience.org/library/papers/41740442PubMed
40612718Anti-candida activity of Lacticaseibacillus rhamnosus R-2002 and its possible application in candidiasis prevention.Iran J Microbiol2025https://conductscience.org/library/papers/40612718PubMed
40529156Dual probiotic and antibiotic therapy targeting bacterial vaginosis: an integrated experimental/computational modeling perspective.Biomed Eng Adv2025https://conductscience.org/library/papers/40529156PubMed
38854974The phenotypic and genotypic antibiotic susceptibility of vaginal Lactobacillus with potential probiotic properties isolated from healthy women in northern Iran.Iran J Microbiol2024https://conductscience.org/library/papers/38854974PubMed
37627701Antibiotic Resistance and Probiotics: Knowledge Gaps, Market Overview and Preliminary Screening.Antibiotics (Basel)2023https://conductscience.org/library/papers/37627701PubMed
35685517Effects of Pro/Prebiotics Alone over Pro/Prebiotics Combined with Conventional Antibiotic Therapy to Treat Bacterial Vaginosis: A Systematic Review.Int J Clin Pract2022https://conductscience.org/library/papers/35685517PubMed
35464937Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span.Front Microbiol2022https://conductscience.org/library/papers/35464937PubMed
35082535Effects of a 10-Strain Oral Probiotic on Parameters of Vaginal Health and Microbial Community: A Pilot Clinical Study.Int J Womens Health2022https://conductscience.org/library/papers/35082535PubMed
34948426Engineering of Vaginal Lactobacilli to Express Fluorescent Proteins Enables the Analysis of Their Mixture in Nanofibers.Int J Mol Sci2021https://conductscience.org/library/papers/34948426PubMed
34925343Tilapia Piscidin 4 (TP4) Reprograms M1 Macrophages to M2 Phenotypes in Cell Models of Gardnerella vaginalis-Induced Vaginosis.Front Immunol2021https://conductscience.org/library/papers/34925343PubMed
33262350Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.Nat Commun2020https://conductscience.org/library/papers/33262350PubMed
32497109Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.PLoS Pathog2020https://conductscience.org/library/papers/32497109PubMed
26137971Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.BMC Infect Dis2015https://conductscience.org/library/papers/26137971PubMed
24900434Potentiating Metronidazole Scaffold against Resistant Trichomonas: Design, Synthesis, Biology and 3D-QSAR Analysis.ACS Med Chem Lett2012https://conductscience.org/library/papers/24900434PubMed
24566190Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24566190PubMed
22219582Bacterial vaginosis: Etiology and modalities of treatment-A brief note.J Pharm Bioallied Sci2011https://conductscience.org/library/papers/22219582PubMed
20657710NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW.Int J Probiotics Prebiotics2008https://conductscience.org/library/papers/20657710PubMed
17485797Antibiotic susceptibility of potentially probiotic vaginal lactobacilli.Infect Dis Obstet Gynecol2006https://conductscience.org/library/papers/17485797PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11368258

GET https://conductscience.org/api/papers/v1/11368258/cited_by?page=2